XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Balance beginning (in shares) at Dec. 31, 2020   71,350,365        
Balance beginning at Dec. 31, 2020 $ 627,209 $ 714 $ 2,535,476 $ (1,874,199) $ (41,806) $ 7,024
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 106,183   106,183      
Stock issued under incentive programs (in shares)   743,019        
Issuance of common stock, net of issuance costs 25,201 $ 7 30,593   (5,399)  
Issuance of common stock, net of issuance costs (in shares)   2,578,967        
Issuance of common stock, net of issuance costs 564,859 $ 26 564,833      
Unrealized loss on marketable securities (9)         (9)
Foreign currency translation adjustment (2,845)         (2,845)
Net income (575,036)     (575,036)    
Balance ending (in shares) at Jun. 30, 2021   74,672,351        
Balance ending at Jun. 30, 2021 745,562 $ 747 3,237,085 (2,449,235) (47,205) 4,170
Balance beginning (in shares) at Mar. 31, 2021   74,470,583        
Balance beginning at Mar. 31, 2021 1,039,127 $ 745 3,180,114 (2,096,918) (44,457) (357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 53,123   53,123      
Stock issued under incentive programs (in shares)   201,768        
Issuance of common stock, net of issuance costs 1,102 $ 2 3,848   (2,748)  
Foreign currency translation adjustment 4,527         4,527
Net income (352,317)     (352,317)    
Balance ending (in shares) at Jun. 30, 2021   74,672,351        
Balance ending at Jun. 30, 2021 745,562 $ 747 3,237,085 (2,449,235) (47,205) 4,170
Balance beginning (in shares) at Dec. 31, 2021   76,433,151        
Balance beginning at Dec. 31, 2021 (351,673) $ 764 3,351,967 (3,617,950) (85,101) (1,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock, net of issuance costs (in shares)   2,200,000        
Issuance of common stock, net of issuance costs     179,000      
Balance ending (in shares) at Mar. 31, 2022   78,722,337        
Balance ending at Mar. 31, 2022 65,324 $ 787 3,566,292 (3,414,542) (85,901) (1,312)
Balance beginning (in shares) at Dec. 31, 2021   76,433,151        
Balance beginning at Dec. 31, 2021 (351,673) $ 764 3,351,967 (3,617,950) (85,101) (1,353)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 70,981   70,981      
Stock issued under incentive programs (in shares)   145,685        
Issuance of common stock, net of issuance costs 951 $ 2 2,303   (1,354)  
Issuance of common stock, net of issuance costs (in shares)   2,197,398        
Issuance of common stock, net of issuance costs 179,385 $ 22 179,363      
Foreign currency translation adjustment (9,517)         (9,517)
Net income (307,077)     (307,077)    
Balance ending (in shares) at Jun. 30, 2022   78,776,234        
Balance ending at Jun. 30, 2022 (416,950) $ 788 3,604,614 (3,925,027) (86,455) (10,870)
Balance beginning (in shares) at Mar. 31, 2022   78,722,337        
Balance beginning at Mar. 31, 2022 65,324 $ 787 3,566,292 (3,414,542) (85,901) (1,312)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 38,048   38,048      
Stock issued under incentive programs (in shares)   53,897        
Issuance of common stock, net of issuance costs (279) $ 1 274   (554)  
Foreign currency translation adjustment (9,558)         (9,558)
Net income (510,485)     (510,485)    
Balance ending (in shares) at Jun. 30, 2022   78,776,234        
Balance ending at Jun. 30, 2022 $ (416,950) $ 788 $ 3,604,614 $ (3,925,027) $ (86,455) $ (10,870)